跳至主要内容
临床试验/NCT00293514
NCT00293514已完成3 期

An Open, Randomised, Prospective, Multi-centre, Parallel-group Trial of TachoSil Versus Standard Surgical Treatment in Patients Undergoing Pulmonary Lobectomy for Lung Malignancy and Requiring Treatment for Air Leakage

Nycomed2 个研究点 分布在 1 个国家开始时间: 2006年2月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Nycomed
试验地点
2
主要终点
Duration of post-operative air leakage: assessment on the evening of the day of operation (Day 0) and then subsequently twice daily (on morning and evening shifts)

研究概览

简要总结

The purpose of this study is to compare the sealing efficacy and safety of TachoSil® (hereafter referred to as TachoSil) versus standard surgical treatment as the secondary management of intra-operative pulmonary air leakage after a lobectomy in subjects with lung malignancies with or without metastases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects with a diagnosis of lung malignancy with or without metastases may be included in the trial if the entry criteria apply.

排除标准

  • 未提供

结局指标

主要结局

Duration of post-operative air leakage: assessment on the evening of the day of operation (Day 0) and then subsequently twice daily (on morning and evening shifts)

次要结局

  • Reduction of intra-operative air leakage intensity after first application of trial treatment

研究者

发起方
Nycomed
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

TachoSil Versus Standard Surgical Treatment for Air... | 临床试验